Part 4/13:
By 2050, just over two decades from now, the trajectory suggests vast advancements in regenerative medicine, gene editing, and nanotechnology. The growth from a few billion to over $42 billion in regenerative medicine demonstrates how quickly medical biotech evolves—what was once purely hypothetical becomes commonplace.